Expression of Excision Repair Cross-Complementation Group 1, Breast Cancer Susceptibility 1, and β III-Tubulin in Thymic Epithelial Tumors

被引:18
作者
Kaira, Kyoichi [1 ]
Serizawa, Masakuni [2 ]
Koh, Yasuhiro [2 ]
Miura, Satoru [1 ]
Kaira, Rieko [1 ]
Abe, Masato [3 ]
Nakagawa, Kazuo [4 ]
Ohde, Yasuhisa [4 ]
Okumura, Takehiro [4 ]
Naito, Tateaki [1 ]
Murakami, Haruyasu [1 ]
Takahashi, Toshiaki [1 ]
Kondo, Haruhiko [4 ]
Nakajima, Takashi [3 ]
Endo, Masahiro [5 ]
Yamamoto, Nobuyuki [1 ]
机构
[1] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka 4118777, Japan
[2] Shizuoka Canc Ctr Res Inst, Div Drug Discovery & Dev, Shizuoka, Japan
[3] Shizuoka Canc Ctr, Div Diagnost Pathol, Shizuoka 4118777, Japan
[4] Shizuoka Canc Ctr, Div Thorac Surg, Shizuoka 4118777, Japan
[5] Shizuoka Canc Ctr, Div Diagnost Radiol, Shizuoka 4118777, Japan
关键词
ERCC1; BRCA1; beta III-tubulin; Thymic epithelial tumor; Platinum-based chemotherapy; CELL LUNG-CANCER; MESSENGER-RNA; ERCC1; SURVIVAL; CISPLATIN; BRCA1; CHEMOTHERAPY;
D O I
10.1097/JTO.0b013e31820b9b35
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We investigated the clinical significance of excision repair cross-complementation group 1 (ERCC1), breast cancer susceptibility 1 (BRCA1), and class III beta-tubulin (TUBB3) expression in thymic epithelial tumors. Method: Fifty-six patients with thymic epithelial tumors were included in this study. Tumors sections were stained by immunohistochemistry for ERCC1, BRCA1, TUBB3, microvessel density, and p53. Results: ERCC1, BRCA1, and TUBB3 were expressed in 48%, 50%, and 27%, respectively. The expression of ERCC1, BRCA1, and TUBB3 was significantly correlated with the grade of malignancy in thymic epithelial tumors. These biomarkers were closely associated with p53 and microvessel density and were a prognostic marker for predicting poor outcome. We also found that overexpression of ERCC1 and TUBB3 was associated with resistance to platinum-and taxane-based chemotherapy. Conclusion: An expression of ERCC1, BRCA1, and TUBB3 was correlated strongly with each other and was significantly associated with a poor outcome in thymic epithelial tumors. High-ERCC1 and TUBB3 expressions might be associated with resistance to platinum- and taxane-based chemotherapy, respectively.
引用
收藏
页码:606 / 613
页数:8
相关论文
共 28 条
[1]  
[Anonymous], 2004, Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs
[2]   The platinum-based treatments for advanced non-small cell lung cancer, is low/negative ERCC1 expression better than high/positive ERCC1 expression? A meta-analysis [J].
Chen, Sufeng ;
Zhang, Jie ;
Wang, Rui ;
Luo, Xiaoyang ;
Chen, Haiquan .
LUNG CANCER, 2010, 70 (01) :63-70
[3]   ERCC1 AND ERCC2 EXPRESSION IN MALIGNANT-TISSUES FROM OVARIAN-CANCER PATIENTS [J].
DABHOLKAR, M ;
BOSTICKBRUTON, F ;
WEBER, C ;
BOHR, VA ;
EGWUAGU, C ;
REED, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (19) :1512-1517
[4]   Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies [J].
Engels, EA ;
Pfeiffer, RM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (04) :546-551
[5]   ERCC1 and Ki67 in Small Cell Lung Carcinoma and Other Neuroendocrine Tumors of the Lung Distribution and Impact on Survival [J].
Guldhammer, Birgit ;
Holm, Bente ;
Erreboe, Anders ;
Skov, Torsten ;
Mellemgaard, Anders .
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (04) :453-459
[6]   Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinoma [J].
Igawa, Satoshi ;
Murakami, Haruyasu ;
Takahashi, Toshiaki ;
Nakamura, Yukiko ;
Tsuya, Asuka ;
Naito, Tateaki ;
Kaira, Kyoichi ;
Ono, Akira ;
Shukuya, Takehito ;
Tamiya, Akihiro ;
Endo, Masahiro ;
Yamamoto, Nobuyuki .
LUNG CANCER, 2010, 67 (02) :194-197
[7]   Microtubules as a target for anticancer drugs [J].
Jordan, MA ;
Wilson, L .
NATURE REVIEWS CANCER, 2004, 4 (04) :253-265
[8]  
Joshi MBM, 2005, CLIN CANCER RES, V11, P2215
[9]  
Kaira K, 2010, EXPERT OPIN MED DIAG, V4, P1
[10]   Biologic Correlation of 2-[18F]-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography in Thymic Epithelial Tumors [J].
Kaira, Kyoichi ;
Endo, Masahiro ;
Abe, Masato ;
Nakagawa, Kazuo ;
Ohde, Yasuhisa ;
Okumura, Takehiro ;
Takahashi, Toshiaki ;
Murakami, Haruyasu ;
Tsuya, Asuka ;
Nakamura, Yukiko ;
Naito, Tateaki ;
Hayashi, Isamu ;
Serizawa, Masakuni ;
Koh, Yasuhiro ;
Hanaoka, Hirofumi ;
Tominaga, Hideyuki ;
Oriuchi, Noboru ;
Kondo, Haruhiko ;
Nakajima, Takashi ;
Yamamoto, Nobuyuki .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) :3746-3753